Piramal Pharma Ltd reports Rs. 90.18 crores consolidated loss in Q3 FY2023

The Board of Directors of Piramal Pharma Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Keywords

,Piramal Pharma ,Piramal Pharma Ltd ,Pharma Limited ,Piramal Pharma Limited ,Piramalpharma ,Q3fy23 ,9mfy23 ,Resultupdate ,Pplpharma ,